In a clinical practice guideline issued by the American Gastroenterological Association and published in Gastroenterology, recommendations are presented relating to use of intragastric balloons (IGBs) for patients with obesity who have failed a trial of conventional weight loss strategies. According to the guidelines, the AGA suggests use of IGB therapy with lifestyle modification over lifestyle modification alone in individuals with obesity seeking a weight loss intervention who have failed a trial of conventional weight loss strategies. For individuals with obesity undergoing IGB therapy, moderate- to high-intensity lifestyle modification interventions are recommended to maintain and augment weight loss. Prophylaxis with proton pump inhibitors is recommended for individuals undergoing IGB therapy. Use of intraoperative anesthetic regimens associated with the lowest incidence of nausea are suggested along with perioperative antiemetics for individuals undergoing IGB therapy. Daily supplementation with one to two adult dose multivitamins are suggested after IGB placement.
